[HTML][HTML] Janus kinase inhibitors in the treatment of vitiligo: a review

F Qi, F Liu, L Gao - Frontiers in immunology, 2021 - frontiersin.org
Vitiligo is a multifactorial reversible skin disorder characterized by distinct white patches that
result from melanocyte destruction. Activated CXCR3+ CD8+ T cells promote melanocyte …

Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo

Y Wang, S Li, C Li - Clinical Reviews in Allergy & Immunology, 2021 - Springer
Vitiligo is an autoimmune disease of the skin characterized by epidermal melanocyte loss
resulting in white patches, with an approximate prevalence of 0.5–2% worldwide. Several …

Social support and posttraumatic growth: A meta-analysis

J Ning, X Tang, H Shi, D Yao, Z Zhao, J Li - Journal of Affective Disorders, 2023 - Elsevier
Background The beneficial role of social support on posttraumatic growth (PTG) has been
assumed by theoretical models and established in some studies. However, there are …

Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study

IH Hamzavi, K Bibeau, P Grimes… - British Journal of …, 2023 - academic.oup.com
Background Vitiligo is a chronic autoimmune disease affecting melanocytes, resulting in skin
depigmentation. Patients with vitiligo often have reduced quality of life and comorbid …

[HTML][HTML] Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis

K Ezzedine, AM Soliman, C Li, HS Camp… - Dermatology and …, 2023 - Springer
Introduction Vitiligo is often associated with comorbid conditions that may increase
economic burden and affect patients' health-related quality of life. No large-scale study has …

[HTML][HTML] Beyond skin white spots: Vitiligo and associated comorbidities

Z Hu, T Wang - Frontiers in Medicine, 2023 - frontiersin.org
Vitiligo is a common depigmentation disorder of an unknown origin characterized by the
selective loss of melanocytes, resulting in typical white macules and patches. However …

[HTML][HTML] Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo

E Guttman-Yassky, E Del Duca, JC Da Rosa… - Journal of Allergy and …, 2024 - Elsevier
Background Vitiligo is an autoimmune depigmenting disorder with no effective and safe
treatments. Its pathogenesis is not fully elucidated. Objective This substudy of a randomized …

[HTML][HTML] Gender differences in vitiligo: psychological symptoms and quality of life assessment description

T Samela, W Malorni, P Matarrese, G Mattia… - Frontiers in …, 2023 - frontiersin.org
Objective Assuming that the difference exist in the manifestation of psychological suffering
among genders, the purpose of this review is to summarize the current knowledge on …

[HTML][HTML] Vitiligo—Thyroid Disease Association: When, in Whom, and Why Should It Be Suspected? A Systematic Review

AM Chivu, E Bălășescu, LD Pandia… - Journal of Personalized …, 2022 - mdpi.com
In most dermatological pathologies, the phenomena observed on the skin are a reflection of
internal disorders. In patients with associated acral involvement on the dorsal sides of the …

Psychiatric and psychologic aspects of chronic skin diseases

RE Christensen, M Jafferany - Clinics in Dermatology, 2023 - Elsevier
Chronic skin diseases can substantially affect a patient's physical, psychologic, and social
well-being. Physicians may play a critical role in identifying and managing the psychologic …